Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.062 | 0.7 |